TY - JOUR
T1 - Validation of prediction model for successful discontinuation of continuous renal replacement therapy
T2 - a multicenter cohort study
AU - Jeon, Junseok
AU - Ko, Eun Jeong
AU - Park, Hyejeong
AU - Baeg, Song In
AU - Kim, Hyung Duk
AU - Min, Ji Won
AU - Koh, Eun Sil
AU - Lee, Kyungho
AU - Kang, Danbee
AU - Cho, Juhee
AU - Lee, Jung Eun
AU - Huh, Wooseong
AU - Chung, Byung Ha
AU - Jang, Hye Ryoun
N1 - Publisher Copyright:
© 2024 by The Korean Society of Nephrology.
PY - 2024/7
Y1 - 2024/7
N2 - Background: Continuous renal replacement therapy (CRRT) has become the standard modality of renal replacement therapy (RRT) in critically ill patients. However, consensus is lacking regarding the criteria for discontinuing CRRT. Here we validated the usefulness of the prediction model for successful discontinuation of CRRT in a multicenter retrospective cohort. Methods: One temporal cohort and four external cohorts included 1,517 patients with acute kidney injury who underwent CRRT for >2 days from 2018 to 2020. The model was composed of four variables: urine output, blood urea nitrogen, serum potassium, and mean arterial pressure. Successful discontinuation of CRRT was defined as the absence of an RRT requirement for 7 days thereafter. Results: The area under the receiver operating characteristic curve (AUROC) was 0.74 (95% confidence interval, 0.71–0.76). The probabilities of successful discontinuation were approximately 17%, 35%, and 70% in the low-score, intermediate-score, and highscore groups, respectively. The model performance was good in four cohorts (AUROC, 0.73–0.75) but poor in one cohort (AUROC, 0.56). In one cohort with poor performance, attending physicians primarily controlled CRRT prescription and discontinuation, while in the other four cohorts, nephrologists determined all important steps in CRRT operation, including screening for CRRT discontinuation. Conclusion: The overall performance of our prediction model using four simple variables for successful discontinuation of CRRT was good, except for one cohort where nephrologists did not actively engage in CRRT operation. These results suggest the need for active engagement of nephrologists and protocolized management for CRRT discontinuation.
AB - Background: Continuous renal replacement therapy (CRRT) has become the standard modality of renal replacement therapy (RRT) in critically ill patients. However, consensus is lacking regarding the criteria for discontinuing CRRT. Here we validated the usefulness of the prediction model for successful discontinuation of CRRT in a multicenter retrospective cohort. Methods: One temporal cohort and four external cohorts included 1,517 patients with acute kidney injury who underwent CRRT for >2 days from 2018 to 2020. The model was composed of four variables: urine output, blood urea nitrogen, serum potassium, and mean arterial pressure. Successful discontinuation of CRRT was defined as the absence of an RRT requirement for 7 days thereafter. Results: The area under the receiver operating characteristic curve (AUROC) was 0.74 (95% confidence interval, 0.71–0.76). The probabilities of successful discontinuation were approximately 17%, 35%, and 70% in the low-score, intermediate-score, and highscore groups, respectively. The model performance was good in four cohorts (AUROC, 0.73–0.75) but poor in one cohort (AUROC, 0.56). In one cohort with poor performance, attending physicians primarily controlled CRRT prescription and discontinuation, while in the other four cohorts, nephrologists determined all important steps in CRRT operation, including screening for CRRT discontinuation. Conclusion: The overall performance of our prediction model using four simple variables for successful discontinuation of CRRT was good, except for one cohort where nephrologists did not actively engage in CRRT operation. These results suggest the need for active engagement of nephrologists and protocolized management for CRRT discontinuation.
KW - Acute kidney injury
KW - Continuous renal replacement therapy
KW - Prediction model
KW - Successful discontinuation
KW - Validation study
UR - http://www.scopus.com/inward/record.url?scp=85198726944&partnerID=8YFLogxK
U2 - 10.23876/j.krcp.23.308
DO - 10.23876/j.krcp.23.308
M3 - Article
AN - SCOPUS:85198726944
SN - 2211-9132
VL - 43
SP - 528
EP - 537
JO - Kidney Research and Clinical Practice
JF - Kidney Research and Clinical Practice
IS - 4
ER -